16.04.2014 Views

efsa-opinion-chromium-food-drinking-water

efsa-opinion-chromium-food-drinking-water

efsa-opinion-chromium-food-drinking-water

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Chromium in <strong>food</strong> and bottled <strong>water</strong><br />

Table J13: Chronic inflammation of the liver in female rats. The benchmark dose (BMD 10 ) and the<br />

95 % benchmark dose lower confidence limit (BMDL 10 ) values are given for a BMR of 10 % extra risk<br />

with characteristics of the model fit. The model with lowest BMDL 10 is highlighted in bold.<br />

Data Dose 0 0.24 0.94 2.4 7.0<br />

Response 12/50 21/50 28/50 35/50 39/50<br />

Models<br />

Restriction<br />

N of<br />

parameters<br />

Minus<br />

Loglikelihood<br />

P-<br />

value<br />

Accepted<br />

BMD 10<br />

(mg/kg<br />

b.w. per<br />

day)<br />

Full model na 5 152.7 – – – –<br />

Null (reduced) model na 1 172.5 - - - -<br />

BMDL 10<br />

(mg/kg<br />

b.w. per<br />

day)<br />

Probit na 2 158.9 0.006 no 0.88 0.70<br />

LogProbit none 3 1.52.9 0.91 yes 0.052 0.0031<br />

Logistic na 2 1.58.7 0.008 no 0.84 0.65<br />

LogLogistic none 3 1.52.8 0.92 yes 0.043 0.0021<br />

Quantal-Linear (QL) na 2 157.0 0.04 no 0.51 0.37<br />

Multistage Cancer na 1 157.0 0.04 no 0.52 0.37<br />

Multistage none 3 153.4 0.51 yes 0.20 0.14<br />

Weibull none 2 153.0 0.82 yes 0.021 0.0005<br />

Gamma none 2 153.1 0.72 yes 0.0096 0.00005<br />

b.w.: body weight; na: not applicable; if: invalid fit.<br />

Multistage Model, with BMR of 10% Extra Risk for the BMD and 0.95 Lower Confidence Limit for the BMDL<br />

Weibull Model, with BMR of 10% Extra Risk for the BMD and 0.95 Lower Confidence Limit for the BMDL<br />

0.9<br />

Multistage<br />

BMD Lower Bound<br />

0.9<br />

Weibull<br />

BMD Lower Bound<br />

0.8<br />

0.8<br />

0.7<br />

0.7<br />

Fraction Affected<br />

0.6<br />

0.5<br />

0.4<br />

Fraction Affected<br />

0.6<br />

0.5<br />

0.4<br />

0.3<br />

0.3<br />

0.2<br />

0.2<br />

0.1<br />

09:17 01/21 2014<br />

BMDL BMD<br />

0 1 2 3 4 5 6 7<br />

dose<br />

0.1<br />

BMDLBMD<br />

0 1 2 3 4 5 6 7<br />

dose<br />

09:15 01/21 2014<br />

Figure J13: Fits of the Multistage model (left) and Weibull model (right) to the dose-response data on<br />

chronic liver inflammation in female rats.<br />

J 2.2.<br />

Diffuse epithelial hyperplasia in the duodenum in male mice<br />

For the dose-response analysis of the incidence of diffuse epithelial hyperplasia in the duodenum in<br />

male mice only one non-restricted model (multistage) showed an acceptable fit (p > 0.05) which<br />

resulted in a BMDL 10 = 0.11 mg/kg b.w. per day . Using a different modelling approach, not following<br />

EFSA (2009), ADTSR reported a BMDL 10 of 0.13 mg/kg b.w. per day. Two graphs in Figure J14 show<br />

the fit of the unrestricted Multistage model and Weibull model.<br />

EFSA Journal 2014;12(3):3595 244

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!